Events Events Events

 
 

Your year-end gift will allow us to seize this critical moment. Please consider giving generously to help shape our future, together.

Learn MoreLearn More

Biogen Presents New ENDEAR Data Showing SPINRAZA (nusinersen) Significantly Reduces Risk of Death or Permanent Ventilation

Biogen presented new data from the Phase 3 ENDEAR study of SPINRAZA™ (nusinersen), which demonstrated

READ MORE

Updated SMA Drug Pipeline Released as First Commercial Patient Receives Spinraza

Updated SMA Drug Pipeline Released as First Commercial Patient Receives Spinraza

With the news today that the first-ever patient has received the first commercial Spinraza dose, we are releasing an updated version of our SMA...

READ MORE

2016 Research Year-in-Review: An Historic Year for Our Community

This has been an historic year for the SMA community. On December 23, the FDA announced its approval of Spinraza, the first-ever approved...

READ MORE

SMA Patient-Focused Drug Development Meeting with FDA Set for April 18, 2017

SMA Patient-Focused Drug Development Meeting with FDA Set for April 18, 2017

Tuesday, April 18, 2017, has been announced as the date for the SMA Patient-Focused Drug Development Meeting with the FDA.

At the...

READ MORE

Cure SMA Assists Hundreds of Families in 2016

Cure SMA Assists Hundreds of Families in 2016

Each year, Cure SMA provides thousands of families with vital support and resources to help them live active, engaged and hopeful...

READ MORE

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software